Evidence map›Paper›PMID 34575601›Full record

ArticlePharmaceutics2021

Endothelial-Derived Extracellular Vesicles Induce Cerebrovascular Dysfunction in Inflammation.

David Roig-Carles, Eduard Willms, Ruud D Fontijn, Sarai Martinez-Pacheco, Imre Mäger, Helga E de Vries, Mark Hirst, Basil Sharrack, David K Male, Cheryl A Hawkes and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07651787 (Neurovascular and Mitochondrial Mechanisms of Transcranial Photobiomodulation in Vascular Mild Cognitive Impairment), which is not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07651787 narecruitingnot on this mapstarted 2025, after this paper: background citation

Neurovascular and Mitochondrial Mechanisms of Transcranial Photobiomodulation in Vascular Mild Cognitive Impairment

TypeinterventionalSponsorUniversity of OklahomaRan2025 to 2026Enrolled40ConditionsMild Cognitive Impairment (MCI), Amyloid PathologyArmsActive Vielight Neuro RX-Duo device -Active transcranial photobiomodulation, Sham Vielight Neuro RX-Duo device -Sham transcranial photobiomodulation
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Frontiers in physiology · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Extracellular Vesicles as "Very Important Particles" (VIPs) in Aging.International journal of molecular sciences · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

David Roig-CarlesSchool of Life, Health and Chemical Sciences, Biomedical Research Network, Open University, Milton Keynes MK7 6AA, UK.ORCID 0000-0003-0553-0425
Eduard WillmsDepartment of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC 3086, Australia.
Ruud D FontijnAmsterdam UMC, Department of Molecular Cell Biology and Immunology, MS Centre Amsterdam, de Boelelaan 1117 VU University, 1081 HZ Amsterdam, The Netherlands.
Sarai Martinez-PachecoSchool of Life, Health and Chemical Sciences, Biomedical Research Network, Open University, Milton Keynes MK7 6AA, UK.ORCID 0000-0002-2924-3140
Imre MägerDepartment of Paediatrics, University of Oxford, Oxford OX3 9DU, UK.
Helga E de VriesAmsterdam UMC, Department of Molecular Cell Biology and Immunology, MS Centre Amsterdam, de Boelelaan 1117 VU University, 1081 HZ Amsterdam, The Netherlands.
Mark HirstSchool of Life, Health and Chemical Sciences, Biomedical Research Network, Open University, Milton Keynes MK7 6AA, UK.
Basil SharrackAcademic Department of Neuroscience and Sheffield NIHR Translational Neuroscience BRC, Sheffield Teaching Hospitals, NHS Foundation Trust, University of Sheffield, Sheffield S10 2JF, UK.
David K MaleSchool of Life, Health and Chemical Sciences, Biomedical Research Network, Open University, Milton Keynes MK7 6AA, UK.
Cheryl A HawkesDepartment of Biomedical and Life Sciences, Lancaster University, Lancaster LA1 4YW, UK.
Ignacio A RomeroSchool of Life, Health and Chemical Sciences, Biomedical Research Network, Open University, Milton Keynes MK7 6AA, UK.
The Open University · GBAmsterdam University Medical Centers · NLLancaster University · GBLa Trobe University · AUSheffield Teaching Hospitals NHS Foundation Trust · GBUniversity of Oxford · GB

Funding

The Open University and National Health Service AMS Project 478957
6 · The paper itself

Abstract

Blood-brain barrier (BBB) dysfunction is a key hallmark in the pathology of many neuroinflammatory disorders. Extracellular vesicles (EVs) are lipid membrane-enclosed carriers of molecular cargo that are involved in cell-to-cell communication. Circulating endothelial EVs are increased in the plasma of patients with neurological disorders, and immune cell-derived EVs are known to modulate cerebrovascular functions. However, little is known about whether brain endothelial cell (BEC)-derived EVs themselves contribute to BBB dysfunction. Human cerebral microvascular cells (hCMEC/D3) were treated with TNFα and IFNy, and the EVs were isolated and characterised. The effect of EVs on BBB transendothelial resistance (TEER) and leukocyte adhesion in hCMEC/D3 cells was measured by electric substrate cell-substrate impedance sensing and the flow-based T-cell adhesion assay. EV-induced molecular changes in recipient hCMEC/D3 cells were analysed by RT-qPCR and Western blotting. A stimulation of naïve hCMEC/D3 cells with small EVs (sEVs) reduced the TEER and increased the shear-resistant T-cell adhesion. The levels of

Indexed as

blood–brain barriercell-to-cell communicationexosomesextracellular vesiclesneuroinflammation

Identifiers

PMID34575601
PMCPMC8472224
OpenAlexW3199439301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.